9:03 AM ET
10-Q
Financial Results
BioAtla Q3 2026 Results: Net Loss of $7.9M, Loss Narrows
BioAtla, Inc. reported a significant reduction in net loss to $13.8 million for the first nine months of 2026, compared to $49.8 million in the prior year, primarily driven by $6.8 million in collaboration revenue and a sharp decrease in R&D spending. However, the company's liquidity position is critical, with cash and cash equivalents dropping to $0.6 million as of September 30, 2026, and a total stockholders' deficit of $43.6 million.
- Key figure
- Net loss $7.9M